Newgenivf Group Limited NIVF
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $23.71M, +6278.9% YoY · Filed Mar 31, 2026
Newgenivf Group Limited (NIVF) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $23.7 million and net income of $9.9 million. Free cash flow was -$11.1 million. As of Dec 31, 2025 it held $758,621 in cash and investments and $510,464 in total debt.
Revenue
$23.71M
+6278.9% vs prior year
Net income
$9.88M
+1983.1% vs prior year
Operating cash flow
$-10.93M
-32.2% vs prior year
Free cash flow
$-11.06M
-33.0% vs prior year
EPS
$3.04
+100.1% vs prior year
Dividend per share
None
Shares outstanding
240,622
+63221.6% vs prior year
Net cash
$248,157
FY 2025
Operating margin
-45.2%
FY 2025
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- NIVF (Nasdaq), NIVFW (Nasdaq)
- Incorporated in
- Virgin Islands, British
- Headquarters
- Bangkok, Thailand
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1981662
- Former names
- ASPAC I Mini Acquisition Corp. (until Mar 1, 2024)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $23.7M | $371,666 | $5.1M |
| Operating income | -$10.7M | -$1.2M | $42,242 |
| Net income | $9.9M | -$524,643 | $130,193 |
| Diluted EPS | $3.04 | -$4,408.76 | $13,019.30 |
| Operating cash flow | -$10.9M | -$8.3M | -$1.8M |
| Free cash flow | -$11.1M | -$8.3M | -$1.8M |
| Total assets | $32.7M | $3.6M | $4.5M |
| Total liabilities | $6.7M | $5.1M | $1.2M |
| Stockholders' equity | $26.6M | -$1.0M | $3.7M |
| Cash and investments | $758,621 | $457,740 | $54,104 |
| Total debt | $510,464 | $118,757 | $652,214 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K/A | Amendment no. 1 to form 6-k | Oct 27, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
All 195 Newgenivf Group Limited SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.